22nd Sep 2005 16:26
ReGen Therapeutics PLC22 September 2005 ReGen Therapeutics Plc22 September 2005 Immediate Release ReGen Therapeutics Plc Declaration of Shareholding Pursuant to the Companies Act 1985, ReGen Therapeutics Plc (the "Company") hasreceived notification on the 22 September 2005 from Wills & Co StockbrokersLimited that it has a beneficial interest in 13,920,000 ordinary shares in theCompany, registered in the name of Pershing Keen Nominees, representingapproximately 3.21% of the current issued share capital. For further information, please contact: Andrew MarshalMarshall Robinson RoeTel. No. 020 7960 6007 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
TILS.L